Literature DB >> 2478112

A new test for endothelial viability. The Janus green photometry technique.

C Hartmann1, P Rieck.   

Abstract

A new in vitro technique was developed to measure, by simple photometry, the amount of Janus green extracted with absolute alcohol from isolated corneas after vital staining. The amount of stain corresponded to the percentage of damaged endothelial cells and was a reliable parameter of endothelial viability. More rapid and easier to perform than the usual cell counting of devitalized cells, this technique can be used to study the endothelial damage induced, for example, by experimental surgery, intraocular solutions, intraocular lens material, corneas storage solutions. As an example of application, results of the endothelial status after medium-term preservation of pig corneas (n = 40) in a modified McCarey-Kaufman medium at 4 degrees C were determined. The mean +/- endothelial damage was 8.5% +/- 1.8% (mean +/- SD) after 4 days, 29.5% +/- 3.7% after 7 days, 45.5% +/- 5.5% after 10 days, 69.3% +/- 3.7% after 14 days, and 100% after 20 days of storage in McCarey-Kaufman medium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478112     DOI: 10.1001/archopht.1989.01070020585045

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Fibroblast growth factor-2 protects endothelial cells from damage after corneal storage at 4 degrees C.

Authors:  Peter W Rieck; Ruth M von Stockhausen; Sylvia Metzner; Christian Hartmann; Yves Courtois
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-06       Impact factor: 3.117

2.  Mastering the infant donor eye: a new device for obtaining corneoscleral buttons for storage and corneal discs for keratoplasty.

Authors:  I N Nartey
Journal:  Br J Ophthalmol       Date:  1991-01       Impact factor: 4.638

3.  Identification and evaluation of a thinning agent compatible with MegaCell DCS, an animal product-free corneal storage medium.

Authors:  Valerie A Smith; Terrell K Johnson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-12       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.